,
. We'll translate the text. Let's do it step by step. First, the lead paragraph: "President Trump added nine more pharmaceutical companies to his drug-pricing deal on Monday, bringing the total to 26 firms that represent 90% of the domestic market. The combined agreements, struck over the past year, are expected to save Americans more than $600 billion. The news lands as healthcare stocks close out their best quarter yet, with UBS arguing the rally has more room to run." Translation: "Præsident Trump tilføjede mandag ni yderligere medicinalvirksomheder til sin medicinprisaftale, hvilket bringer det samlede antal op på 26 virksomheder, der repræsenterer 90% af det indenlandske marked. De samlede aftaler, indgået i løbet af det seneste år, forventes at spare amerikanerne for mere end 600 milliarder dollars. Nyheden kommer, mens sundhedsaktier lukker deres bedste kvartal hidtil, og UBS argumenterer for, at opturen har mere at give." We'll keep "President Trump" as is, but in Danish we might say "Præsident Trump" - that's fine. Now the first section: "The expanded pricing framework" - "Den udvidede prisramme" or "Den udvidede prisfastsættelsesramme"? We'll use "Den udvidede prisaftale" maybe. But the heading is "The expanded pricing framework" - we can translate as "Den udvidede prisramme" or "Den udvidede prisstruktur". I'll use "Den udvidede prisramme". Content: "The nine additional firms are mostly midsize drugmakers, including Alcon, Astellas Pharma, and Teva Pharmaceuticals. They pledged $19.6 billion combined toward U.S. manufacturing and agreed to offer their drugs to every state Medicaid program at discounted prices. The White House said 17 companies had already joined the pricing framework over the past year, meaning the latest additions bring the total to 26." Translation: "De ni ekstra virksomheder er for det meste mellemstore medicinalproducenter, herunder Alcon, Astellas Pharma og Teva Pharmaceuticals. De lovede tilsammen 19,6 milliarder dollars til amerikansk produktion og accepterede at tilbyde deres lægemidler til alle statslige Medicaid-programmer til nedsatte priser. Det Hvide Hus sagde, at 17 virksomheder allerede havde tilsluttet sig prisrammen i løbet af det seneste år, hvilket betyder, at de seneste tilføjelser bringer det samlede antal op på 26." We'll keep "Medicaid" as is. Second section: "Why UBS sees more upside" - "Hvorfor UBS ser mere optur" or "Hvorfor UBS ser yderligere potentiale". I'll use "Hvorfor UBS ser mere optur". Content: "UBS's Michael Yee said the advance reflects a stack of major clinical wins and that new pricing deals have calmed fears of a broader industry crackdown. He said pharmaceutical companies are sitting on record cash piles and pushing more into R&D after a multiyear stretch of cheap valuations. Yee added that valuations are still not stretched and Washington's pricing overhang is easing, making the current move look like the start of a longer re-rating." Translation: "UBS's Michael Yee sagde, at fremgangen afspejler en stak af store kliniske sejre, og at nye prisaftaler har dæmpet frygten for en bredere industrinedfældning. Han sagde, at medicinalvirksomheder sidder på rekordstore kontantbeholdninger og skubber mere ind i forskning og udvikling efter en flerårig periode med billige værdiansættelser. Yee tilføjede, at værdiansættelserne stadig ikke er strakte, og at Washingtons prispres er ved at lette, hvilket får den nuværende bevægelse til at ligne starten på en længere re-rating." We'll keep "re-rating" as is, or translate as "genvurdering" but it's a financial term, often kept in English. We'll use "re-rating" in quotes. Third section: "The clinical wins fueling the move" - "De kliniske sejre, der driver bevægelsen" or "De kliniske sejre bag opturen". I'll use "De kliniske sejre, der driver opturen". Content: "Merck's melanoma vaccine, developed with Moderna, met its main trial goals in a large trial involving more than 1,100 patients, with results reported on August 19. The FDA approved Revolution Medicines' pancreatic cancer drug daraxonrasib on August 26, which nearly doubled median survival in a late-stage trial compared with chemotherapy. Merck's antibody-drug conjugate sacituzumab tirumotecan posted a positive lung cancer trial readout earlier this year and is now being tested across 17 late-stage studies." Translation: "Mercks melanomvaccine, udviklet sammen med Moderna, opfyldte sine vigtigste forsøgsmål i et stort forsøg med mere end 1.100 patienter, med resultater rapporteret den 19. august. FDA godkendte Revolution Medicines' bugspytkirtelkræftmedicin daraxonrasib den 26. august, som næsten fordoblede medianoverlevelsen i et sent fase-forsøg sammenlignet med kemoterapi. Mercks antistof-lægemiddelkonjugat sacituzumab tirumotecan viste positive resultater i et lungekræftforsøg tidligere på året og testes nu i 17 sent fase-studier." We'll keep drug names as is. Fourth section: "Yee also named Bristol Myers Squibb as a top pick, with UBS carrying a Buy rating and expecting several late-stage trial readouts before year-end. The SPDR S&P Biotech ETF (XBI) has climbed 80% in the last 12 months, a sign of the sector's momentum. Investors will be watching for those Bristol Myers readouts, along with any further additions to the pricing framework." Translation: "Yee næ